At 17.8% CAGR, the Europe Artificial Cervical Intervertebral Disc Market is projected to be worth US$ 1,321.29 million by 2028, says Business Market Insights      

According to Business Market Insights’ research, the Europe artificial cervical intervertebral disc market was valued at US$ 495.03 million in 2022 and is expected to reach US$ 1,321.29 million by 2028, registering an annual growth rate of 17.8%  from 2022 to 2028. Growing incidences of cervical injuries and rising aging population are the critical factors attributed to the market expansion.              

Trauma is the major contributor to cervical injuries, including vehicle accidents, penetrating or blunt trauma, falls, and sports or diving injuries. Further, most sports injuries are orthopedic injuries, including strains, sprains, fractures, broken ligaments, pain, and swelling; these may be acute or chronic. The incidence of sports injuries increases with increased participation in sports and active participation in fitness activities due to the growing focus on healthy living. Therefore, the demand for the artificial cervical intervertebral disc is increasing due to the rising incidences of cervical injuries.  

On the contrary, high cost of cervical intervertebral disc surgeries hurdles the growth of Europe artificial cervical intervertebral disc market.

The Europe artificial cervical intervertebral disc market, based on material, has been bifurcated into biopolymer material and metal material. The biopolymer material segment held 62.7% market share in 2022, amassing US$ 310.16 million. It is projected to garner US$ 819.24 million by 2028 to expand at 17.6% CAGR during 2022–2028.

The Europe artificial cervical intervertebral disc market based on end user is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held 49.2% market share in 2022, amassing US$ 243.54 million. It is projected to garner US$ 655.92 million by 2028 to expand at 18.0% CAGR during 2022–2028.

Based on country, the Europe artificial cervical intervertebral disc market is fragmented into Germany, the UK, France, Italy, Spain, and rest of Europe. Our regional analysis states that Germany captured 26.7% market share in 2022. It was assessed at US$ 132.10 million in 2022 and is likely to hit US$ 356.29 million by 2028, exhibiting a CAGR of 18.0% during the forecast period.  

Key players dominating the Europe artificial cervical intervertebral disc market are Aditus Medical; B. Braun Melsugen AG.; Centinel Spine, LLC; Globus Medical, Inc.; Medtronic; NuVasive, Inc.; Orthofix Medical, Inc.; and Zimmer Biomet Holdings, Inc. among others.

• In Sept 2021, Orthofix Medical’s more than 60,000 M6-C artificial cervical discs have been implanted worldwide. The implant is a next-generation artificial disc designed to mimic the natural motion of a native disc. Developed to replace an intervertebral disc damaged by cervical disc degeneration, the M6-C disc is indicated as an alternative to cervical fusion. First approved for distribution under the CE Mark in the European Union and other international geographies, the M6-C disc received U.S. Food and Drug Administration (FDA) approval in 2019.

In Sept 2020, Orthhofix Medical, Inc. partnered with Neo Medical SA, a privately held Switzerland-based medical device company for development of novel spinal surgery-related products.